Capecitabine, DNA/RNA Synthesis Inhibitor

Capecitabine is an oral proagent that is converted to its active metabolite, 5-FU, by thymidine phosphorylase. - Mechanism of Action & Protocol.

HY-17371-100mg Oxaliplatin [61825-94-3] Hexabiogen

5‑Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review)

Capecitabine, C15H22FN3O6

Structures and mode of action of antimetabolites and DHFR inhibitors.

Thymidine Monophosphate - an overview

Cancer & Cancer Drug

DNA and RNA Synthesis: Antifolates

Biomedicines, Free Full-Text

Targeting nucleotide metabolism as the nexus of viral infections, cancer, and the immune response

Frontiers PARP inhibitors combined with radiotherapy: are we ready?

Results for DNA Synthesis Abcam: antibodies, proteins, kits

5-FU (5-Fluorouracil), 99.97%(HPLC), In Stock

THOC5 complexes with DDX5, DDX17, and CDK12 to regulate R loop structures and transcription elongation rate

Dihydropyrimidine Dehydrogenase-Mediated Resistance to 5-Fluorouracil: Mechanistic Investigation and Solution